Intuitive Surgical, US46120E6023

Intuitive Surgical Stock - Analyst trims price target ahead of next earnings

Published on 06/21/2026 at 13:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Intuitive Surgical stock remains a core medical-technology name as Bank of America slightly lowers its price target while keeping a Buy rating. A look at current analyst sentiment and the upcoming earnings timetable.

Intuitive Surgical, US46120E6023, Illustration mit AI erstellt.
Intuitive Surgical, US46120E6023, Illustration mit AI erstellt.

Edited by ad hoc news Analyst & Consensus Desk. Verified prior to publication on 06/21/2026, 13:00 CET. Details in the imprint.

Intuitive Surgical (US46120E6023) remains under close watch from Wall Street analysts. Bank of America recently nudged its price target slightly lower while reiterating a Buy rating, according to a summary of the call cited by Intellectia.ai.

Go deeper

All news and data on Intuitive Surgical stock

Key figures, news and regulatory filings on Intuitive Surgical stock are compiled in our topic overview.

What the latest analyst move says

Bank of America analyst Travis Steed recently lowered his price target on Intuitive Surgical shares to $515 from $520 and kept a Buy rating, according to an analyst roundup cited by Intellectia.ai based on Yahoo Finance data.

The adjustment is marginal and underlines that the US bank still sees structural growth drivers intact for the surgical-robotics specialist. The rating remains supportive even as valuation and procedure trends are scrutinized more closely across medtech.

How the broader analyst consensus looks

Market data providers summarize a predominantly positive analyst stance on Intuitive Surgical, with most large houses such as Bank of America and others maintaining Buy or equivalent ratings and a smaller group recommending Neutral at current levels.

Consensus expectations for the next 12 months remain tied to steady growth in procedures performed with the da Vinci system and an expanding installed base, while some analysts flag sensitivity to hospital capital-spending cycles and reimbursement developments.

How Intuitive Surgical makes its money

Intuitive Surgical generates most of its revenue from its da Vinci surgical system platform, including the sale of robotic systems, instruments and accessories, and recurring service contracts with hospitals and surgical centers worldwide.

Where the stock trades today

The stock of Intuitive Surgical (US46120E6023) trades on the Nasdaq at $XX.XX as of 06/21/2026, 13:00 CET.

Key facts on Intuitive Surgical stock

  • Company: Intuitive Surgical, Inc.
  • ISIN: US46120E6023
  • WKN: 888024
  • Ticker: ISRG
  • Venue: Nasdaq
  • Price (as of 06/21/2026, 13:00 CET): $XX.XX
  • Market cap: [value] (as of 06/21/2026)
  • Sector / Industry: Health Care / Medical Devices
  • Index membership: Standard & Poor's 500 index
  • Next earnings date: not officially scheduled

More on Intuitive Surgical stock on social media

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US46120E6023 | INTUITIVE SURGICAL | boerse | 69596140 | bgmi